TALK WITH US.
WE’VE BEEN THERE.
We are prostate cancer survivors,
here to answer your prostate cancer questions.
The office is open Monday-Thursday from 10-2.
Phone calls are answered seven days a week.
Call or email for information on support group meetings or for free, one-on-one support.
Contact Us
Call: (505) 254-7784 (7 days/week)
Email: pchelp@pcsanm.org
Visit: 2533 Virginia St NE, Suite C Albuquerque, NM 87110
Annual Conference
Our 10th annual conference
was a success!
MEETINGS
Our bi-weekly meetings are now virtual:
click below to for how to participate
Free Library & Resources
We have a library with helpful books and information in our office.
Approximately 1 in 8 men will get prostate cancer.
PCSANM helps men and their families cope with this disease.
We offer:
- Publications and other reading materials on a wide variety of prostate cancer subjects
- Free one-on-one consultations for those diagnosed with prostate cancer and those dealing with the diagnosis of a loved one
- A list of survivors willing to discuss their treatment experience and side effects
- Bi-monthly support meetings including presentations by medical professionals expert in prostate cancer and related topics
- Outreach activities at conferences and health fairs
- Educational presentations to organizations
- Vouchers for free PSA tests for those who have no medical insurance, no primary care physician, or are experiencing troubling symptoms
We offer education, information, and support and will share our experiences with prostate cancer treatments and side effects.
What’s New
FDA Clears Insightec’s MRI-Guided Sound Wave Technology to Treat Prostate Cancer
The Exablate Prostate system, guided by MRI technology, directs sound waves toward cancerous prostate tissue, destroying only the malignant tissue and preserving the healthy structures nearby.
MRI: Can It Be Used to Plan Ablative Therapies?
View this presentation by Robert E. Reiter, MD, during the 31st International Prostate Cancer Update in July 2021 in Snowbird, Utah.
FDA Approves TLX591-CDx Prostate Cancer Imaging Product, Making 68Ga-based PSMA-PET More Accessible
TLX591-CDx is the first commercially available product approved by the FDA that will broaden access to 68Ga-based PSMA-PET imaging for patients within the United States who are eligible to receive it.
Would you like to support PCSANM?
Volunteer
Contact us to learn more
OUTREACH
Contact us to learn more
Donate
How to Donate